Anti-HCV prevalence among diabetic and non-diabetic Egyptian children

H El-Karaksy1, G H Anwar, M S El-Raziky

  • 1Department of Pediatrics, Cairo University, Cairo, Egypt.

Current Diabetes Reviews
|October 1, 2010
PubMed

Insights

Hepatitis C virus (HCV) infection prevalence was similar in children with type 1 diabetes and non-diabetic children. Standard infection control measures can prevent HCV spread in pediatric diabetes units, even in high-prevalence areas like Egypt.

Area of Science:

  • Pediatric Endocrinology
  • Infectious Diseases
  • Hepatology

Background:

  • Type 1 diabetes (T1DM) management involves frequent medical interventions, raising concerns about potential infection transmission.
  • Hepatitis C virus (HCV) is a significant public health concern, particularly in Egypt, a country with a high HCV burden.

Purpose of the Study:

  • To determine the prevalence of HCV infection in children with T1DM compared to non-diabetic children.
  • To investigate potential risk factors for HCV infection in these pediatric populations.

Main Methods:

  • A comparative study involving 692 children with T1DM and 1042 non-diabetic children from Cairo University Pediatric Hospital.
  • Screening for anti-HCV antibodies using third-generation ELISA.
  • Assessment of exposure to medical care, personal hygiene practices, and environmental factors.

Main Results:

  • Anti-HCV antibody prevalence was comparable between diabetic (2.5%) and non-diabetic (1.4%) children below 9 years of age (p=0.25).
  • Children with T1DM showed higher exposure to medical care, including daily insulin injections and blood glucose monitoring (p=0.04).
  • Non-diabetic children reported higher exposure to shared razors (p=0.05) and traditional haircutting practices (p=0.05).

Conclusions:

  • HCV prevalence is similar in young children with and without type 1 diabetes.
  • Implementing standard infection control precautions is effective in preventing HCV transmission within pediatric diabetes units.
  • The findings underscore the importance of infection control in managing T1DM in high HCV prevalence settings.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...